Author Correction: Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Author Correction: Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma ; volume:15 ; number:1 ; day:20 ; month:11 ; year:2024 ; pages:1 ; date:12.2024
Nature Communications ; 15, Heft 1 (20.11.2024), 1, 12.2024

Klassifikation
Recht

Urheber
Flesken-Nikitin, Andrea
Ralston, Coulter Q.
Fu, Dah-Jiun
Micheli, Andrea J. De
Phuong, Daryl J.
Harlan, Blaine A.
Ashe, Christopher S.
Armstrong, Amanda P.
McKellar, David W.
Ghuwalewala, Sangeeta
Ellenson, Lora H.
Schimenti, John C.
Cosgrove, Benjamin D.
Nikitin, Alexander Yu
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41467-024-54465-x
URN
urn:nbn:de:101:1-2502062113579.148987318751
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:36 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Flesken-Nikitin, Andrea
  • Ralston, Coulter Q.
  • Fu, Dah-Jiun
  • Micheli, Andrea J. De
  • Phuong, Daryl J.
  • Harlan, Blaine A.
  • Ashe, Christopher S.
  • Armstrong, Amanda P.
  • McKellar, David W.
  • Ghuwalewala, Sangeeta
  • Ellenson, Lora H.
  • Schimenti, John C.
  • Cosgrove, Benjamin D.
  • Nikitin, Alexander Yu
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma

Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma

IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis

IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis

High-grade serous ovarian cancer: the clone wars

High-grade serous ovarian cancer: the clone wars

High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis

High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis

Prognostic Significance of Chemotherapy Response Score in Patients Undergoing Interval Debulking Surgery and Attained Complete Cytoreduction for High-Grade Serous Tubal and Ovarian Carcinoma

Prognostic Significance of Chemotherapy Response Score in Patients Undergoing Interval Debulking Surgery and Attained Complete Cytoreduction for High-Grade Serous Tubal and Ovarian Carcinoma

First-Line Management of Advanced High-Grade Serous Ovarian Cancer

First-Line Management of Advanced High-Grade Serous Ovarian Cancer

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer

Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer

Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer

Principles of dormancy evident in high-grade serous ovarian cancer

Principles of dormancy evident in high-grade serous ovarian cancer

Tubal-Kain

Tubal-Kain

MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma

MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma

No evidence for PALB2 methylation in high-grade serous ovarian cancer

No evidence for PALB2 methylation in high-grade serous ovarian cancer

Verbundene Objekte